{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:55:35Z","timestamp":1756810535138},"reference-count":44,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,12]]},"DOI":"10.7759\/cureus.9685","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T12:59:56Z","timestamp":1597237196000},"source":"Crossref","is-referenced-by-count":7,"title":["The Sickle Effect: The Silent Titan Affecting Glycated Hemoglobin Reliability"],"prefix":"10.7759","author":[{"given":"Domonick K","family":"Gordon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madiha","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhat","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safeera","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2015.1.160","article-title":"Sickle cell trait diagnosis: clinical and social implications","volume":"2015","author":"Naik RP","year":"2015","unstructured":"Naik RP, Haywood C Jr. Sickle cell trait diagnosis: clinical and social implications. Hematology Am Soc Hematol Educ Program. 2015, 2015:160-167. 10.1182\/asheducation-2015.1.160","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.4.623","article-title":"The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes","volume":"22","author":"The Diabetes Prevention Program Research Group","year":"1999","unstructured":"The Diabetes Prevention Program Research Group. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999, 22:623-634. 10.2337\/diacare.22.4.623","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1179","article-title":"Detection of abnormal glucose tolerance in Africans is improved by combining A1C with fasting glucose: the Africans in America Study","volume":"38","author":"Sumner AE","year":"2015","unstructured":"Sumner AE, Thoreson CK, O'Connor MY, et al.. Detection of abnormal glucose tolerance in Africans is improved by combining A1C with fasting glucose: the Africans in America Study. Diabetes Care. 2015, 38:213-219. 10.2337\/dc14-1179","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01416","article-title":"Genetic ancestry markers and difference in A1c between African American and White in the Diabetes Prevention Program","volume":"104","author":"Hivert MF","year":"2019","unstructured":"Hivert MF, Christophi CA, Jablonski KA, et al.. Genetic ancestry markers and difference in A1c between African American and White in the Diabetes Prevention Program. J Clin Endocrinol Metab. 2019, 104:328-336. 10.1210\/jc.2018-01416","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212552","article-title":"Evaluation of agreement between hemoglobin A1c, fasting glucose, and fructosamine in Senegalese individuals with and without sickle-cell trait","volume":"14","author":"Skinner S","year":"2019","unstructured":"Skinner S, Diaw M, Ndour Mbaye M, et al.. Evaluation of agreement between hemoglobin A1c, fasting glucose, and fructosamine in Senegalese individuals with and without sickle-cell trait. PLoS One. 2019, 14:0212552. 10.1371\/journal.pone.0212552","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.21035","article-title":"Association of sickle cell trait with hemoglobin A1c in African Americans","volume":"317","author":"Lacy ME","year":"2017","unstructured":"Lacy ME, Wellenius GA, Sumner AE, et al.. Association of sickle cell trait with hemoglobin A1c in African Americans. JAMA. 2017, 317:507-515. 10.1001\/jama.2016.21035","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22271","article-title":"Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications","volume":"87","author":"Goldsmith JC","year":"2012","unstructured":"Goldsmith JC, Bonham VL, Joiner CH, Kato GJ, Noonan AS, Steinberg MH. Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications. Am J Hematol. 2012, 87:340-346. 10.1002\/ajh.22271","journal-title":"Am J Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-S002","article-title":"2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes - 2020","volume":"43","author":"American Diabetes Association","year":"2020","unstructured":"American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes - 2020. Diabetes Care. 2020, 43:S14-S31. 10.2337\/dc20-S002","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2007.s91","article-title":"Tests of glycemia in diabetes","volume":"27","author":"Goldstein DE","year":"2004","unstructured":"Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, Sacks DB. Tests of glycemia in diabetes. Diabetes Care. 2004, 27:s91-s93. 10.2337\/diacare.27.2007.s91","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1894","article-title":"Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes","volume":"97","author":"Herman WH","year":"2012","unstructured":"Herman WH, Cohen RM. Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes. J Clin Endocrinol Metab. 2012, 97:1067-1072. 10.1210\/jc.2011-1894","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0982","article-title":"Sickle cell trait, European ancestry, and longitudinal tracking of HbA1c among African Americans: the Jackson Heart Study","volume":"42","author":"Echouffo-Tcheugui JB","year":"2019","unstructured":"Echouffo-Tcheugui JB, Mwasongwe SE, Sims M, Dagogo-Jack S, Golden SH, Correa A, Musani SK. Sickle cell trait, European ancestry, and longitudinal tracking of HbA1c among African Americans: the Jackson Heart Study. Diabetes Care. 2019, 42:e166-e167. 10.2337\/dc19-0982","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00533","article-title":"A1C underperforms as a diagnostic test in Africans even in the absence of nutritional deficiencies, anemia and hemoglobinopathies: insight from the Africans in America study","volume":"10","author":"Briker SM","year":"2019","unstructured":"Briker SM, Aduwo JY, Mugeni R, et al.. A1C underperforms as a diagnostic test in Africans even in the absence of nutritional deficiencies, anemia and hemoglobinopathies: insight from the Africans in America study. Front Endocrinol (Lausanne). 2019, 10:533. 10.3389\/fendo.2019.00533","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref13","unstructured":"Sumandeep Vidyapeeth Institutional Repository. Study of blood sugar levels and glycosylated hemoglobin in patients of sickle cell hemoglobinopathy (Doctoral dissertation). (2018). Accessed. April 2020: http:\/\/14.139.121.113:8083\/jspui\/handle\/123456789\/444."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007293","article-title":"Common \u03b1-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease","volume":"14","author":"Raffield LM","year":"2018","unstructured":"Raffield LM, Ulirsch JC, Naik RP, et al.. Common \u03b1-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease. PLoS Genet. 2018, 14:e1007293. 10.1371\/journal.pgen.1007293","journal-title":"PLoS Genet"},{"key":"ref15","article-title":"Association between hemoglobin A1c and glycemia in African Americans with and without sickle cell trait and Whites. Results from CARDIA and the Jackson Heart Study","volume":"2018","author":"Wu WC","year":"2018","unstructured":"Wu WC, Lacy ME, Correa A, Carnethon M, Reiner AP, Eaton CB, Wellenius GA. Association between hemoglobin A1c and glycemia in African Americans with and without sickle cell trait and Whites. Results from CARDIA and the Jackson Heart Study. J Diabetes Treat. 2018, 2018:163.","journal-title":"J Diabetes Treat"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2010.03050.x","article-title":"The impact of sickle cell trait on glycated hemoglobin in diabetes mellitus","volume":"27","author":"Bleyer AJ","year":"2010","unstructured":"Bleyer AJ, Vidya S, Sujata L, et al.. The impact of sickle cell trait on glycated hemoglobin in diabetes mellitus. Diabet Med. 2010, 27:1012-1016. 10.1111\/j.1464-5491.2010.03050.x","journal-title":"Diabet Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2002.007088","article-title":"Conditions associated with very low values of glycohemoglobin measured by an HPLC method","volume":"57","author":"Camargo JL","year":"2004","unstructured":"Camargo JL, Gross JL. Conditions associated with very low values of glycohemoglobin measured by an HPLC method. J Clin Pathol. 2004, 57:346-349. 10.1136\/jcp.2002.007088","journal-title":"J Clin Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1159\/000208316","article-title":"Red cell life span in sickle cell trait","volume":"51","author":"Barbedo MM","year":"1974","unstructured":"Barbedo MM, McCurdy PR. Red cell life span in sickle cell trait. Acta Haematol. 1974, 51:339-343. 10.1159\/000208316","journal-title":"Acta Haematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V33.2.214.214","article-title":"32-DFP and 51-Cr for measurement of red cell life span in abnormal hemoglobin syndromes","volume":"33","author":"McCurdy PR","year":"1969","unstructured":"McCurdy PR. 32-DFP and 51-Cr for measurement of red cell life span in abnormal hemoglobin syndromes. Blood. 1969, 33:214-224. 10.1182\/blood.V33.2.214.214","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V14.3.255.255","article-title":"Distribution of abnormal hemoglobins in Puerto Rico and survival studies of red blood cells using Cr51","volume":"14","author":"Suarez RM","year":"1959","unstructured":"Suarez RM, Buso R, Meyer LM, Olavarrieta ST. Distribution of abnormal hemoglobins in Puerto Rico and survival studies of red blood cells using Cr51. Blood. 1959, 14:255-261. 10.1182\/blood.V14.3.255.255","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V9.12.1155.1155","article-title":"Radioactive sodium chromate for the study of survival of red blood cells: III, the abnormal hemoglobin syndromes","volume":"9","author":"Weinstein I","year":"1954","unstructured":"Weinstein I, Spurling C, Klein H, Necheles TF. Radioactive sodium chromate for the study of survival of red blood cells: III, the abnormal hemoglobin syndromes. Blood. 1954, 9:1155-1164. 10.1182\/blood.V9.12.1155.1155","journal-title":"Blood"},{"key":"ref22","article-title":"Sickle cell disease: studied by measuring the survival of transfused red blood cells","volume":"34","author":"Callender ST","year":"1949","unstructured":"Callender ST, Nickel JF. Sickle cell disease: studied by measuring the survival of transfused red blood cells. J Lab Clin Med. 1949, 34:90-104.","journal-title":"J Lab Clin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5555\/uri:pii:0022214348903011","article-title":"The life span of the sickle cell and the pathogenesis of sickle cell anemia","volume":"33","author":"Singer K","year":"1948","unstructured":"Singer K, Robin S. The life span of the sickle cell and the pathogenesis of sickle cell anemia. J Lab Clin Med. 1948, 33:975-984. 10.5555\/uri:pii:0022214348903011","journal-title":"J Lab Clin Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171315","article-title":"Effect of ethnicity on HbA1c levels in individuals without diabetes: systematic review and meta-analysis","volume":"12","author":"Cavagnolli G","year":"2017","unstructured":"Cavagnolli G, Pimentel AL, Freitas PA, Gross JL, Camargo JL. Effect of ethnicity on HbA1c levels in individuals without diabetes: systematic review and meta-analysis. PLoS One. 2017, 12:e0171315. 10.1371\/journal.pone.0171315","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2337\/dc05-1973","article-title":"Disparities in HbA1c levels between African-American and non-Hispanic White adults with diabetes: a meta-analysis","volume":"29","author":"Kirk J","year":"2006","unstructured":"Kirk J, Agostino R, Bell R, Passmore LV, Bonds DE, Karter AJ, Venkat Narayan KM. Disparities in HbA1c levels between African-American and non-Hispanic White adults with diabetes: a meta-analysis. Diabetes Care. 2006, 29:2130-2136. 10.2337\/dc05-1973","journal-title":"Diabetes Care"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-12-201006150-00004","article-title":"Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies","volume":"152","author":"Ziemer DC","year":"2010","unstructured":"Ziemer DC, Kolm P, Weintraub WS, et al.. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med. 2010, 152:770-777. 10.7326\/0003-4819-152-12-201006150-00004","journal-title":"Ann Intern Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2003","article-title":"Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program","volume":"30","author":"Herman WH","year":"2007","unstructured":"Herman WH, Ma Y, Uwaifo G, et al.. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007, 30:2453-2457. 10.2337\/dc06-2003","journal-title":"Diabetes Care"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7326\/M17-1231","article-title":"Variability in the relationship of hemoglobin A1c and average glucose concentrations: how much does race matter?","volume":"167","author":"Selvin E","year":"2017","unstructured":"Selvin E, Sacks DB. Variability in the relationship of hemoglobin A1c and average glucose concentrations: how much does race matter?. Ann Intern Med. 2017, 167:131-132. 10.7326\/M17-1231","journal-title":"Ann Intern Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/BF00404798","article-title":"Unexplained variability of glycated hemoglobin in non-diabetic subjects not related to glycemia","volume":"33","author":"Yudkin JS","year":"1990","unstructured":"Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ. Unexplained variability of glycated hemoglobin in non-diabetic subjects not related to glycemia. Diabetologia. 1990, 33:208-215. 10.1007\/BF00404798","journal-title":"Diabetologia"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-154112","article-title":"Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c","volume":"112","author":"Cohen RM","year":"2008","unstructured":"Cohen RM, Franco RS, Khera PK, et al.. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood. 2008, 112:4284-4291. 10.1182\/blood-2008-04-154112","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2337\/db07-1820","article-title":"Evidence for inter-individual variation in the glucose gradient across the human RBC membrane and its relationship to Hb1c","volume":"57","author":"Khera PK","year":"2008","unstructured":"Khera PK, Joiner CH, Carruthers A, et al.. Evidence for inter-individual variation in the glucose gradient across the human RBC membrane and its relationship to Hb1c. Diabetes. 2008, 57:2445-2452. 10.2337\/db07-1820","journal-title":"Diabetes"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.12.2858","article-title":"HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins","volume":"50","author":"Snieder H","year":"2001","unstructured":"Snieder H, Sawtell PA, Ross L, Walker J, Spector TD, Leslie RD. HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes. 2001, 50:2858-2863. 10.2337\/diabetes.50.12.2858","journal-title":"Diabetes"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0286","article-title":"Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in non-diabetic twins","volume":"29","author":"Cohen RM","year":"2006","unstructured":"Cohen RM, Snieder H, Lindsell CJ, et al.. Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in non-diabetic twins. Diabetes Care. 2006, 29:1739-1743. 10.2337\/dc06-0286","journal-title":"Diabetes Care"},{"key":"ref34","article-title":"Incidence of sickle cell trait - United States, 2010","volume":"63","author":"Ojodu J","year":"2014","unstructured":"Ojodu J, Hulihan MM, Pope SN, Grant AM, Centers for Disease Control and Prevention (CDC). Incidence of sickle cell trait - United States, 2010. MMWR Morb Mortal Wkly Rep. 2014, 63:1155-1158.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002383","article-title":"Impact of common genetic determinants of hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: a transethnic genome-wide meta-analysis","volume":"14","author":"Wheeler E","year":"2017","unstructured":"Wheeler E, Leong A, Liu CT, et al.. Impact of common genetic determinants of hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: a transethnic genome-wide meta-analysis. PLoS Med. 2017, 14:e1002383. 10.1371\/journal.pmed.1002383","journal-title":"PLoS Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2008.12.005","article-title":"The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis","volume":"42","author":"Nkhoma ET","year":"2009","unstructured":"Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009, 42:267-278. 10.1016\/j.bcmd.2008.12.005","journal-title":"Blood Cells Mol Dis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.1.163","article-title":"Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy","volume":"26","author":"Cohen R","year":"2003","unstructured":"Cohen R, Holmes YR, Chenier TC, Joiner CH. Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care. 2003, 26:163-167. 10.2337\/diacare.26.1.163","journal-title":"Diabetes Care"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1767","article-title":"Evidence for consistency of the glycation gap in diabetes","volume":"34","author":"Nayak AU","year":"2011","unstructured":"Nayak AU, Holland MR, Macdonald DR, Nevill A, Singh BM. Evidence for consistency of the glycation gap in diabetes. Diabetes Care. 2011, 34:1712-1716. 10.2337\/dc10-1767","journal-title":"Diabetes Care"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0953","article-title":"2010 Consensus statement on the worldwide standardization of the hemoglobin A1C measurement","volume":"33","author":"Hanas R","year":"2010","unstructured":"Hanas R, John G, International HBA1c Consensus Committee. 2010 Consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care. 2010, 33:1903-1904. 10.2337\/dc10-0953","journal-title":"Diabetes Care"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-Sint","article-title":"Introduction: Standards of Medical Care in Diabetes - 2020","volume":"43","author":"American Diabetes Association","year":"2020","unstructured":"American Diabetes Association. Introduction: Standards of Medical Care in Diabetes - 2020. Diabetes Care. 2020, 43:S1-S2. 10.2337\/dc20-Sint","journal-title":"Diabetes Care"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.5581\/1516-8484.20130048","article-title":"Sickle cell anemia: clinical diversity and beta S-globin haplotypes","volume":"35","author":"Loggetto SR","year":"2013","unstructured":"Loggetto SR. Sickle cell anemia: clinical diversity and beta S-globin haplotypes. Rev Bras Hematol Hemoter. 2013, 35:155-157. 10.5581\/1516-8484.20130048","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/1891019a0","article-title":"Site of binding of chromium-51 to hemoglobin","volume":"189","author":"Pearson HA","year":"1961","unstructured":"Pearson HA, Vertrees KM. Site of binding of chromium-51 to hemoglobin. Nature. 1961, 189:1019-1020. 10.1038\/1891019a0","journal-title":"Nature"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V28.4.563.563","article-title":"The binding of Cr51 to hemoglobin: II. In vivo elution rates of Cr51 from Hb CC, Hb CS and placental red cells","volume":"28","author":"Pearson HA","year":"1966","unstructured":"Pearson HA. The binding of Cr51 to hemoglobin: II. In vivo elution rates of Cr51 from Hb CC, Hb CS and placental red cells. Blood. 1966, 28:563-568. 10.1182\/blood.V28.4.563.563","journal-title":"Blood"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2017.09.011","article-title":"Average glucose from hemoglobin A1c for altered red blood cell lifetimes: predictions based on a model for hemoglobin A1c formation","volume":"474","author":"Molinaro R","year":"2017","unstructured":"Molinaro R, Herman JH, Stickle DF. Average glucose from hemoglobin A1c for altered red blood cell lifetimes: predictions based on a model for hemoglobin A1c formation. Clin Chim Acta. 2017, 474:124-129. 10.1016\/j.cca.2017.09.011","journal-title":"Clin Chim Acta"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/36738-the-sickle-effect-the-silent-titan-affecting-glycated-hemoglobin-reliability","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:21:08Z","timestamp":1707506468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/36738-the-sickle-effect-the-silent-titan-affecting-glycated-hemoglobin-reliability"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":44,"URL":"https:\/\/doi.org\/10.7759\/cureus.9685","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,12]]}}}